Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Epileptic Generalized Tonic-clonic Seizure”

65 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 65 results

Large-scale testing (Phase 3)Study completedNCT00231556
What this trial is testing

A Study on Safety and Efficacy of Two Doses of Topiramate as Monotherapy in the Treatment of Newly Diagnosed or Recurrent Epilepsy

Who this might be right for
EpilepsySeizuresEpilepsies, Partial+2 more
Johnson & Johnson Pharmaceutical Research & Development, L.L.C. 750
Large-scale testing (Phase 3)Study completedNCT03678753
What this trial is testing

Randomized, Double-Blind Study to Evaluate Efficacy and Safety of Cenobamate Adjunctive Therapy in PGTC Seizures

Who this might be right for
Primary Generalized Epilepsy
SK Life Science, Inc. 169
Large-scale testing (Phase 3)Looking for participantsNCT05667142
What this trial is testing

Evaluate XEN1101 as Adjunctive Therapy in Primary Generalized Tonic-Clonic Seizures

Who this might be right for
Primary Generalized Tonic-Clonic Seizures
Xenon Pharmaceuticals Inc. 160
Large-scale testing (Phase 3)Study completedNCT02823145
What this trial is testing

An Open-Label Extension Trial to Assess the Long-Term Safety of ZX008 (Fenfluramine Hydrochloride HCl) Oral Solution in Children and Young Adults With Dravet Syndrome

Who this might be right for
Dravet Syndrome
Zogenix International Limited, Inc., a subsidiary of Zogenix, Inc. 375
Large-scale testing (Phase 3)Study completedNCT00210782
What this trial is testing

A Comparison of the Effectiveness and Safety of Topiramate and Phenytoin in Patients With New Onset Epilepsy Requiring Rapid Initiation of Antiepileptic Drug Treatment

Who this might be right for
Epilepsy
Johnson & Johnson Pharmaceutical Research & Development, L.L.C. 262
Testing effectiveness (Phase 2)Study completedNCT01118962
What this trial is testing

Open-Label Extension Study to Assess the Safety and Seizure Frequency Associated With Lacosamide for Primary Generalized Tonic-Clonic Seizures in Subjects With Epilepsy

Who this might be right for
Epilepsy
UCB BIOSCIENCES, Inc. 39
Large-scale testing (Phase 3)Study completedNCT01463306
What this trial is testing

A 12-Month Study To Evaluate The Safety And Tolerability Of Pregabalin As Add-On Therapy In Pediatric Subjects 1 Month To 16 Years Of Age With Partial Onset Seizures And Pediatric And Adult Subjects 5 To 65 Years Of Age With Primary Generalized Tonic-Clonic Seizures

Who this might be right for
Epilepsy, Partial SeizuresEpilepsy, Primary Generalized Tonic-Clonic Seizures
Pfizer's Upjohn has merged with Mylan to form Viatris Inc. 605
Post-approval studies (Phase 4)Study completedNCT00266604
What this trial is testing

Evaluate the Dosing, Effectiveness and Safety of Topiramate for the Treatment of Epilepsy

Who this might be right for
EpilepsySeizuresEpilepsies, Partial+2 more
Johnson & Johnson Pharmaceutical Research & Development, L.L.C. 409
Post-approval studies (Phase 4)Study completedNCT00510783
What this trial is testing

IV Keppra in the Emergency Department for Prevention of Early Recurrent Seizures

Who this might be right for
Tonic-clonic Seizure
Emory University 158
Large-scale testing (Phase 3)Study completedNCT02682927
What this trial is testing

A Trial of Two Fixed Doses of ZX008 (Fenfluramine HCl) in Children and Young Adults With Dravet Syndrome

Who this might be right for
Dravet SyndromeSeizure Disorder
Zogenix International Limited, Inc., a subsidiary of Zogenix, Inc. 262
Post-approval studies (Phase 4)Looking for participantsNCT06967012
What this trial is testing

A Clinical Study on the Efficacy and Safety of Zonisamide as a First Add-On Treatment in Epileptic Seizures

Who this might be right for
Epilepsies, PartialEpilepsy, Tonic-Clonic
Affiliated Hospital of Nantong University 30
Large-scale testing (Phase 3)Study completedNCT00236704
What this trial is testing

The Efficacy and Safety of Topiramate as "Add on" Treatment in Epilepsy Patients With Primary Generalized Tonic-clonic Seizures

Who this might be right for
EpilepsySeizures
Johnson & Johnson Pharmaceutical Research & Development, L.L.C. 80
Large-scale testing (Phase 3)Ended earlyNCT03299842
What this trial is testing

Assess the Usability of the Embrace Seizure Detection Watch in Children and Young Adults With Dravet Syndrome

Who this might be right for
Dravet Syndrome
Zogenix International Limited, Inc., a subsidiary of Zogenix, Inc. 5
Not applicableUnknownNCT02661919
What this trial is testing

Assessment of the Emfit Mattress Sensor for Detection and Alarm of Night-time Generalized Tonic-clonic Seizures.

Who this might be right for
EpilepsySeizures
Emfit, Corp. 50
Large-scale testing (Phase 3)Study completedNCT02408549
What this trial is testing

Safety and Efficacy of Lacosamide as Additional Therapy in Patients Suffering From Epileptic Tonic-Clonic Seizures

Who this might be right for
Epilepsy
UCB BIOSCIENCES, Inc. 239
Not applicableStudy completedNCT03059381
What this trial is testing

Investigation of the Clinical Safety and Efficacy of Long-term Treatment With Fycompa Tablets in Adolescence Epilepsy Patients With Partial-onset Seizures (With or Without Secondary Generalized Seizures) or Primary Generalized Tonic-clonic Seizures

Who this might be right for
Partial Seizures (With or Without Secondary Generalized Seizures)Primary Generalized Tonic-clonic Seizures
Eisai Co., Ltd. 519
Not applicableNo Longer AvailableNCT02307578
What this trial is testing

An Extended Access Program (EAP) for Perampanel

Who this might be right for
Primary Generalized Tonic-Clonic or Partial Onset SeizuresLennox Gastaut Syndrome
Eisai Inc.
Large-scale testing (Phase 3)Study completedNCT00104416
What this trial is testing

Study Evaluating LAMICTAL Extended-Release Therapy Added To Current Seizure Treatments In Patients With Primary Generalized Tonic-Clonic Seizures (PGTC) Seizures

Who this might be right for
Epilepsy, Tonic-Clonic
GlaxoSmithKline 153
Large-scale testing (Phase 3)Study completedNCT00236418
What this trial is testing

The Efficacy and Safety of Topiramate in Epilepsy Patients With Primary Generalized Tonic-clonic Seizures

Who this might be right for
EpilepsySeizures
Johnson & Johnson Pharmaceutical Research & Development, L.L.C. 80
Large-scale testing (Phase 3)Study completedNCT01465997
What this trial is testing

Evaluating Long Term Safety of Lacosamide (LCM) to Carbamazepine Controlled-release (CBZ-CR); Initial Monotherapy in Epilepsy Subjects 16 Years and Older

Who this might be right for
EpilepsyMonotherapy
UCB BIOSCIENCES GmbH 551
Next Page